HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Clinical trials for HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Tumor-Seeking' radiation drug enters human trials for tough cancers
Disease control Recruiting nowThis study is testing a new type of cancer drug that delivers radiation directly to tumors by targeting a protein called Nectin-4. It aims to find a safe and effective dose for patients with advanced solid cancers who have already tried other treatments. The trial will first dete…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New scan aims to sharpen the picture of stubborn breast cancer
Diagnosis Recruiting nowThis early-stage study is testing a new radioactive imaging tracer called 68Ga-R10602 to see if it can better locate tumors in people with advanced, hormone-positive breast cancer. The study will enroll about 36 adults whose cancer has progressed despite prior treatments. The mai…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC